Literature DB >> 10982615

Comparative clinicopathological study of resected intrahepatic cholangiocarcinoma in northeast Thailand and Japan.

H Suzuki1, S Isaji, C Pairojkul, T Uttaravichien.   

Abstract

Northeast Thailand has a very high incidence of intrahepatic cholangiocarcinoma (ICC), which is closely linked to infestation by the liver fluke, whereas the etiology of ICC in Japan remains to be clarified. This study compared the clinicopathological features, the expression of p53 and c-erbB-2 proteins, and the proliferative activity of ICC in 19 Thai and 23 Japanese patients with ICC who were treated by hepatic resection. The average age of the Thai patients (55.8 years) was lower than that of the Japanese (61.3 years). All Thai patients presented with symptoms, whereas 8 Japanese patients were asymptomatic. There were no significant differences in preoperative liver function test values. Tumors were less likely to be located in the right lobe in the Japanese (34.8%) than in the Thai patients (63.2%). Peribiliary fibrosis and adenomatous hyperplasia in noncancerous hepatic tissues were much more frequently found in the Thai patients (P = 0.0010; P<0.0001). No significant differences in the expression of p53 protein or c-erbB-2 protein were found between the two series of patients, but proliferative activity, evaluated on the basis of mean MIB1 labeling index, was significantly higher in the Thai patients (P<0.001). The present study suggested a higher proliferative activity of ICC in Thai patients than in Japanese patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10982615     DOI: 10.1007/s005340050177

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Surg        ISSN: 0944-1166


  11 in total

1.  Expression of phosphorylated ERK1/2 and homeodomain protein CDX2 in cholangiocarcinoma.

Authors:  Artit Jinawath; Yoshimitsu Akiyama; Yasuhito Yuasa; Chawalit Pairojkul
Journal:  J Cancer Res Clin Oncol       Date:  2006-06-23       Impact factor: 4.553

2.  Prognostic analysis of surgical treatment of peripheral cholangiocarcinoma: two decades of experience at Chang Gung Memorial Hospital.

Authors:  Yi-Yin Jan; Chun-Nan Yeh; Ta-Sen Yeh; Tse-Ching Chen
Journal:  World J Gastroenterol       Date:  2005-03-28       Impact factor: 5.742

3.  Clinicopathological factors predicting long-term overall survival after hepatectomy for peripheral cholangiocarcinoma.

Authors:  Yi-Yin Jan; Chun-Nan Yeh; Ta-Sen Yeh; Tsann-Long Hwang; Miin-Fu Chen
Journal:  World J Surg       Date:  2005-07       Impact factor: 3.352

4.  Expression of insulin-like growth factor I receptor as a biomarker for predicting prognosis in biliary tract cancer patients.

Authors:  Hideo Suzuki; Juan C Roa; Toru Kawamoto; Kazunori Ishige; Ignacio I Wistuba; Donghui Li; Melanie B Thomas; Junichi Shoda
Journal:  Mol Clin Oncol       Date:  2015-02-25

5.  FAT, E-cadherin, beta catenin, HER 2/neu, Ki67 immuno-expression, and histological grade in intrahepatic cholangiocarcinoma.

Authors:  J Settakorn; N Kaewpila; G F Burns; A S-Y Leong
Journal:  J Clin Pathol       Date:  2005-12       Impact factor: 3.411

6.  The risk factors and diagnosis of cholangiocarcinoma.

Authors:  Christopher A Wadsworth; Adrian Lim; Simon D Taylor-Robinson; Shahid A Khan
Journal:  Hepatol Int       Date:  2012-11-10       Impact factor: 6.047

Review 7.  Role of ErbB family receptor tyrosine kinases in intrahepatic cholangiocarcinoma.

Authors:  Alphonse-E Sirica
Journal:  World J Gastroenterol       Date:  2008-12-14       Impact factor: 5.742

Review 8.  Cholangiocarcinoma: lessons from Thailand.

Authors:  Banchob Sripa; Chawalit Pairojkul
Journal:  Curr Opin Gastroenterol       Date:  2008-05       Impact factor: 3.287

Review 9.  HER2/HER3 pathway in biliary tract malignancies; systematic review and meta-analysis: a potential therapeutic target?

Authors:  Salvatore Galdy; Angela Lamarca; Mairéad G McNamara; Richard A Hubner; Chiara A Cella; Nicola Fazio; Juan W Valle
Journal:  Cancer Metastasis Rev       Date:  2017-03       Impact factor: 9.264

10.  Ultrasound screening for cholangiocarcinoma could detect premalignant lesions and early-stage diseases with survival benefits: a population-based prospective study of 4,225 subjects in an endemic area.

Authors:  Prakongboon Sungkasubun; Surachate Siripongsakun; Kunlayanee Akkarachinorate; Sirachat Vidhyarkorn; Akeanong Worakitsitisatorn; Thaniya Sricharunrat; Sutida Singharuksa; Rawisak Chanwat; Chairat Bunchaliew; Sirima Charoenphattharaphesat; Ruechuta Molek; Maneenop Yimyaem; Gaidganok Sornsamdang; Kamonwan Soonklang; Kasiruck Wittayasak; Chirayu U Auewarakul; Chulabhorn Mahidol
Journal:  BMC Cancer       Date:  2016-06-02       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.